Microbiologics notes that as of 1 January 2026, FDA's ISTAND programme listed 16 projects in development, 14 accepted Letters of Intent, 2 accepted Qualification Plans, and no qualified drug development tool.
Published
Signal category
Research & Knowledge
Quote
“As of 1 January 2026, FDA's ISTAND programme listed 16 projects in development, 14 accepted Letters of Intent, 2 accepted Qualification Plans, and no qualified drug development tool.”
— Stefano Gaburro, PhD|Microbiologics team
Company
Microbiologics
The world's go-to partners for infectious disease biomaterials and testing services.
- Industry
- Biotechnology Research
- Location
- Saint Cloud, US
- Company size
- 428 employees
We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan.
Founded 1971